Benign prostatic hyperplasia (BPH) is a complex disease that is progressive in many men.
BPH is commonly associated with bothersome lower urinary tract symptoms; progressive …

BACKGROUND: Combination therapy with dutasteride and tamsulosin provides significantly
greater benefit than either monotherapy for various patient-reported outcomes in men with …

Background: Benign prostatic hyperplasia (BPH) is often associated with enlargement of the
prostate gland, lower urinary tract symptoms, decreased urinary flow and a reduced quality …

What's known on the subject? and What does the study add? Treatment of benign prostatic
hyperplasia (BPH) centres on two drug classes, 5α‐reductase inhibitors and α‐blockers. The …

Benign prostatic hyperplasia (BPH) is a clinical diagnosis. While BPH is a common cause of
lower urinary tract symptoms (LUTS) in men, LUTS can signify a number of other disease …

Benign prostatic hyperplasia (BPH) represents a significant burden in ageing men due to
frequently associated lower urinary tract symptoms (LUTS), which may impair quality of life …

Background We performed a meta-analysis to confirm the efficacy and safety of the
combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in …

As demographics change, with the elderly constituting an increasing proportion of the
population, the prevalence of benign prostatic hyperplasia (BPH) is increasing, with a …

Objective To investigate whether a fixed‐dose combination (FDC) of 0.5 mg dutasteride and
0.4 mg tamsulosin is more effective than watchful waiting with protocol‐defined initiation of …

PURPOSE: We reviewed recent literature and treatment guidelines regarding the
prevalence, pathophysiology, and management of BPO related to BPH; and management of …